… to identify cardiovascular prognostic factors associated with morbidity and mortality in COVID-19
… testing of biomarkers of cardiovascular performance in COVID-19 to optimise outcomes. …

… of cardiovascular biomarkers in COVID-19. Cardiac troponin As a quantitative marker of
cardiomyocyte injury, the concentrations of cardiac troponin in a patient with COVID-19 should …

… the importance of cardiac biomarkers in the diagnostics and therapeutics of COVID 19. …
of cardiac biomarkers elevation in COVID 19 but also various hematological and biochemical …

… cardiovascular disorders and mortality in COVID-19 patients admitted to ICU, this study
provides critical information regarding cardiac injury and its link with survival in COVID-19. …

… patients with COVID-19. The purpose of this review was to offer a concise summary on …
cardiac biomarkers in COVID-19 and discuss whether routine measurements of these biomarkers …

… cardiac biomarker elevations and the severity of COVID-19 … reflect the effect of COVID-19
on cardiac health in the infected … two major cardiac biomarkers that are affected by COVID-19 …

… , a comprehensive early assessment of cardiac biomarkers may be pragmatically used to …
with cardiac biomarkers in a wide population of hospitalized patients with COVID-19. …

… related to the severity of COVID-19. Our meta-analysis of … cardiac biomarkers at admission
in patients with COVID-19 … COVID-19 patients with cardiac abnormality biomarkers test …

… We only evaluated admission biomarker levels and did not … of cardiovascular and inflammatory
biomarkers on admission for prognostic purposes in patients hospitalized for COVID-19. …

… markers for COVID-19 prognosis with … cardiac biomarker pattern in COVID-19 patients
was significantly associated with increased mortality risk, and the newly established COVID-19 …